Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOZANTINIB S-MALATE Cause Wound complication? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Wound complication have been filed in association with CABOZANTINIB S-MALATE (CABOMETYX). This represents 0.0% of all adverse event reports for CABOZANTINIB S-MALATE.

5
Reports of Wound complication with CABOZANTINIB S-MALATE
0.0%
of all CABOZANTINIB S-MALATE reports
1
Deaths
1
Hospitalizations

How Dangerous Is Wound complication From CABOZANTINIB S-MALATE?

Of the 5 reports, 1 (20.0%) resulted in death, 1 (20.0%) required hospitalization.

Is Wound complication Listed in the Official Label?

Yes, Wound complication is listed as a known adverse reaction in the official FDA drug label for CABOZANTINIB S-MALATE.

What Other Side Effects Does CABOZANTINIB S-MALATE Cause?

Diarrhoea (8,282) Fatigue (6,819) Off label use (5,245) Nausea (4,341) Decreased appetite (4,076) Blood pressure increased (2,939) Malignant neoplasm progression (2,718) Palmar-plantar erythrodysaesthesia syndrome (2,706) Weight decreased (2,657) Stomatitis (2,560)

What Other Drugs Cause Wound complication?

ADALIMUMAB (509) BECAPLERMIN (448) COLLAGENASE CLOSTRIDIUM HISTOLYTICUM (148) PREDNISONE (142) METFORMIN (85) ATORVASTATIN (84) CLONAZEPAM (82) OMALIZUMAB (81) ALENDRONATE (76) INFLIXIMAB (72)

Which CABOZANTINIB S-MALATE Alternatives Have Lower Wound complication Risk?

CABOZANTINIB S-MALATE vs CAFFEINE CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL CABOZANTINIB S-MALATE vs CALASPARGASE PEGOL-MKNL CABOZANTINIB S-MALATE vs CALCIFEDIOL CABOZANTINIB S-MALATE vs CALCIPOTRIENE

Related Pages

CABOZANTINIB S-MALATE Full Profile All Wound complication Reports All Drugs Causing Wound complication CABOZANTINIB S-MALATE Demographics